Rescue Pharmacotherapy for OSA

Summary

Rescue Pharmacotherapy for OSA is a clinical trial^[1].

Key Facts

• Rescue Pharmacotherapy for OSA is in the country of United States^[2].
• Rescue Pharmacotherapy for OSA's instance of is recorded as clinical trial^[3].
• Rescue Pharmacotherapy for OSA's start time is recorded as +2022-09-01T00:00:00Z^[4].
• Rescue Pharmacotherapy for OSA's end time is recorded as +2023-12-01T00:00:00Z^[5].
• Rescue Pharmacotherapy for OSA's main subject is recorded as apnea^[6].
• Rescue Pharmacotherapy for OSA's number of participants is recorded as {'unit': '1', 'amount': '+70'}^[7].
• Rescue Pharmacotherapy for OSA's title is recorded as Treating Residual OSA With Endotype-directed Pharmacotherapy (Aim 3)^[8].
• Rescue Pharmacotherapy for OSA's short name is recorded as RescOSA^[9].
• Rescue Pharmacotherapy for OSA's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}^[10].
• Rescue Pharmacotherapy for OSA's ClinicalTrials.gov ID is recorded as NCT05293600^[11].
• Rescue Pharmacotherapy for OSA's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[12].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as acetazolamide^[13].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as eszopiclone^[14].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as trazodone^[15].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as atomoxetine hydrochloride^[16].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as adrenergic uptake inhibitors^[17].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as membrane transport modulator^[18].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as mechanism of action^[19].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as adrenergic agent^[20].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as neurotransmitter agent^[21].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as Carbonic Anhydrase Inhibitors^[22].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as enzyme inhibitor^[23].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as ATC code C03^[24].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as hypnotics and sedatives^[25].
• Rescue Pharmacotherapy for OSA's research intervention is recorded as depressant^[26].